AbbVie Inc. (ABBV) stock
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)
Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%
AbbVie profit margin
Profit margin (net margin) is net income as a percentage of revenue.
AbbVie's profit margin for the twelve months ending Jun 30, 2026 was 9.8%. For fiscal 2025 it was 6.9%, against 7.6% the year before. The highest annual figure on record is 23.7% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.9% | −0.7 |
| FY2024 | Dec 31, 2024 | 7.6% | −1.4 |
| FY2023 | Dec 31, 2023 | 9.0% | −11.4 |
| FY2022 | Dec 31, 2022 | 20.4% | −0.2 |
| FY2021 | Dec 31, 2021 | 20.5% | +10.5 |
| FY2020 | Dec 31, 2020 | 10.1% | −13.6 |
| FY2019 | Dec 31, 2019 | 23.7% | +6.3 |
| FY2018 | Dec 31, 2018 | 17.4% | −1.5 |
| FY2017 | Dec 31, 2017 | 18.8% | −4.4 |
| FY2016 | Dec 31, 2016 | 23.2% | +0.7 |
| FY2015 | Dec 31, 2015 | 22.5% | +13.6 |
| FY2014 | Dec 31, 2014 | 8.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 21.3% | +15.2 |
| Q1 FY2026 | Mar 31, 2026 | 4.6% | −5.0 |
| Q4 FY2025 | Dec 31, 2025 | 10.9% | +11.1 |
| Q3 FY2025 | Sep 30, 2025 | 1.2% | −9.6 |
| Q2 FY2025 | Jun 30, 2025 | 6.1% | −3.4 |
| Q1 FY2025 | Mar 31, 2025 | 9.6% | −1.5 |
| Q4 FY2024 | Dec 31, 2024 | -0.1% | −5.9 |
| Q3 FY2024 | Sep 30, 2024 | 10.8% | −2.0 |
| Q2 FY2024 | Jun 30, 2024 | 9.5% | −5.1 |
| Q1 FY2024 | Mar 31, 2024 | 11.1% | +9.2 |
| Q4 FY2023 | Dec 31, 2023 | 5.7% | −10.6 |
| Q3 FY2023 | Sep 30, 2023 | 12.8% | −13.9 |
| Q2 FY2023 | Jun 30, 2023 | 14.6% | +8.3 |
| Q1 FY2023 | Mar 31, 2023 | 2.0% | −31.2 |
| Q4 FY2022 | Dec 31, 2022 | 16.4% | −10.8 |
| Q3 FY2022 | Sep 30, 2022 | 26.7% | +4.5 |
| Q2 FY2022 | Jun 30, 2022 | 6.3% | +0.8 |
| Q1 FY2022 | Mar 31, 2022 | 33.2% | +5.9 |
| Q4 FY2021 | Dec 31, 2021 | 27.2% | +26.9 |
| Q3 FY2021 | Sep 30, 2021 | 22.2% | +4.3 |
| Q2 FY2021 | Jun 30, 2021 | 5.5% | +12.6 |
| Q1 FY2021 | Mar 31, 2021 | 27.3% | −7.6 |
| Q4 FY2020 | Dec 31, 2020 | 0.3% | −31.9 |
| Q3 FY2020 | Sep 30, 2020 | 17.9% | −4.3 |
| Q2 FY2020 | Jun 30, 2020 | -7.1% | −16.1 |
| Q1 FY2020 | Mar 31, 2020 | 34.9% | +3.5 |
| Q4 FY2019 | Dec 31, 2019 | 32.2% | +54.2 |
| Q3 FY2019 | Sep 30, 2019 | 22.2% | −11.1 |
| Q2 FY2019 | Jun 30, 2019 | 9.0% | −15.0 |
| Q1 FY2019 | Mar 31, 2019 | 31.4% | −3.7 |
| Q4 FY2018 | Dec 31, 2018 | -22.0% | −22.7 |
| Q3 FY2018 | Sep 30, 2018 | 33.4% | +10.0 |
| Q2 FY2018 | Jun 30, 2018 | 24.0% | −3.6 |
| Q1 FY2018 | Mar 31, 2018 | 35.1% | +8.9 |
| Q4 FY2017 | Dec 31, 2017 | 0.7% | −19.8 |
| Q3 FY2017 | Sep 30, 2017 | 23.3% | −1.5 |
| Q2 FY2017 | Jun 30, 2017 | 27.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 26.2% | – |
| Q4 FY2016 | Dec 31, 2016 | 20.5% | – |
| Q3 FY2016 | Sep 30, 2016 | 24.8% | – |
See a number that looks wrong?